Volkmar Müller
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- Oncology top 0.2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
- Cancer Research 154
- Breast Cancer Treatment Studies 79
- Cancer Genomics and Diagnostics 64
- Oncology 230
- HER2/EGFR in Cancer Research 99
- Cancer Cells and Metastasis 81
- Cancer Treatment and Pharmacology 51
- Lung Cancer Research Studies 23
- Co-authors
- Klaus PantelHeidi SchwarzenbachWolfgang JanniSabine RiethdorfKarin Milde‐LangoschBrigitte RackTanja FehmF. Jänicke
- Journals
- Cancer Research (31 papers)Breast Care (22 papers)Breast Cancer Research and Treatment (21 papers)Journal of Clinical Oncology (19 papers)Breast Cancer Research (13 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Volkmar Müller
302 papers receiving 11.4k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 5.9k
- Oncology 6.7k
- Pulmonary and Respiratory Medicine 2.4k
- Molecular Biology 4.4k
- Radiology, Nuclear Medicine and Imaging 907
Countries citing papers authored by Volkmar Müller
This map shows the geographic impact of Volkmar Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkmar Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkmar Müller more than expected).
Fields of papers citing papers by Volkmar Müller
This network shows the impact of papers produced by Volkmar Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkmar Müller. The network helps show where Volkmar Müller may publish in the future.
Co-authors
The 25 scholars most cited alongside Volkmar Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 0 | |
| 7 | 2020 | 26 | |
| 8 | 2020 | 25 | |
| 9 | 2019 | 27 | |
| 10 | 2018 | 8 | |
| 11 | 2017 | 82 | |
| 12 | 2015 | 65 | |
| 13 | 2015 | 30 | |
| 14 | 2012 | 126 | |
| 15 | 2011 | 55 | |
| 16 | 2011 | 39 | |
| 17 | 2010 | 15 | |
| 18 | 2010 | 50 | |
| 19 | Expression and prognostic value of activating transcription factor 2 (ATF2) and its phosphorylated form in mammary carcinomas. | 2009 | 18 |
| 20 | 2007 | 27 |
About Volkmar Müller
Volkmar Müller is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 319 papers that have together received 11.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (99 papers), Cancer Cells and Metastasis (81 papers), Breast Cancer Treatment Studies (79 papers), Advanced Breast Cancer Therapies (69 papers), Cancer Genomics and Diagnostics (64 papers), Cancer Treatment and Pharmacology (51 papers), Brain Metastases and Treatment (32 papers) and Lung Cancer Research Studies (23 papers). The work is most often cited by research in Cancer Research (5.9k citations), Oncology (6.7k citations), Pulmonary and Respiratory Medicine (2.4k citations), Molecular Biology (4.4k citations) and Radiology, Nuclear Medicine and Imaging (907 citations). Volkmar Müller has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Klaus Pantel, Heidi Schwarzenbach, Wolfgang Janni, Sabine Riethdorf, Karin Milde‐Langosch, Brigitte Rack, Tanja Fehm, F. Jänicke, Isabell Witzel and Thomas Rau. Their work appears in journals such as Cancer Research, Breast Care, Breast Cancer Research and Treatment, Journal of Clinical Oncology and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.